These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 937372)

  • 1. The investigation and treatment of renal bone disease.
    Catto GR; MacLeod M
    Am J Med; 1976 Jul; 61(1):64-73. PubMed ID: 937372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The investigation and treatment of renal osteodystrophy.
    Catto GR; MacLeod M; Pelc B; Kodicek E
    Proc Eur Dial Transplant Assoc; 1975; 11():473-80. PubMed ID: 1197272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body in-vivo neutron activation analysis in assessing treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
    Naik RB; Gosling P; Price CP; Robinson BH; Dabek JT; Heath DA; James HM; Kanis JA; Smith R
    Br Med J; 1976 Jul; 2(6027):79-83. PubMed ID: 1276820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 1alpha-hydroxyvitamin D3 on calcium and mineral content of bone in renal osteodystrophy.
    Junor BJ; Catto GR
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():131s-138s. PubMed ID: 606411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience in the behavior and control of renal osteodystrophy in patients under chronic hemodialysis].
    Treviño Becerra A
    Gac Med Mex; 1975 Jun; 109(6):411-20. PubMed ID: 1149988
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
    Winney RJ; Bone JM; Anderson TJ; Robson JS
    Calcif Tissue Res; 1977 May; 22 Suppl():94-100. PubMed ID: 912593
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical picture, diagnosis and therapy of renal osteodystrophy].
    Bombor H
    Z Urol Nephrol; 1977 Aug; 70(8):603-7. PubMed ID: 335702
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
    Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
    Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25-hydroxycholecalciferol in the treatment of renal osteodystrophy in haemodialysed patients.
    Coen G; Taccone-Gallucci M; Bonucci E; Bianchini G; Gallucci G; Lucentini G; Matteucci MC; Picca S; Casciani CU
    Int J Artif Organs; 1979 Nov; 2(6):278-81. PubMed ID: 511368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of whole body and regional assessments of calcium balance in renal osteodystrophy in the response to 1 alpha-hydroxy vitamin D3.
    Naik RB; Robertson PW; Robinson BH; Dabek JT; James HM; Kanis JA
    Proc Eur Dial Transplant Assoc; 1977; 14():425-32. PubMed ID: 600960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of whole body calcium in chronic renal failure: effects of 1alpha-hydroxyvitamin D3 and parathyroidectomy.
    Naik RB; Dabek JT; Heynen G; James HM; Kanis JA; Robertson PW; Robinson BH; Woods CG
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():139s-145s. PubMed ID: 564247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy.
    Silverberg DS; Bettcher KB; Dossetor JB; Overton TR; Holick MF; DeLuca HF
    Can Med Assoc J; 1975 Jan; 112(2):190, 193-5. PubMed ID: 1111876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of uremic osteodystrophy].
    Fletti C; Docci D; Coli' L; Di Felice A
    G Clin Med; 1981 Apr; 62(4):270-9. PubMed ID: 7021295
    [No Abstract]   [Full Text] [Related]  

  • 15. [1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy].
    Chalmers TM; Davie MW; Hunter JO; Szaz KF
    J Urol Nephrol (Paris); 1974 Dec; 80(12):981. PubMed ID: 4617778
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vivo analysis of calcium content by localized neutronic radioactivation using a source of californium 252. Value in renal osteodystrophy].
    Zech P; Guey A; Leitienne PH; Meary MF; Pozet N; Moskovtchenko JF; Traeger J
    J Urol Nephrol (Paris); 1976; 82(4-5):315-9. PubMed ID: 781302
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy].
    Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M
    Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial body calcium measurements on patients with renal failure.
    Harrison JE; McNeill KG; Meema HE; Oreopoulos D; Rabinovich S; Fenton S; Wilson DR
    Metabolism; 1977 Mar; 26(3):255-65. PubMed ID: 834154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis].
    Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M
    Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure.
    Witmer G; Margolis A; Fontaine O; Fritsch J; Lenoir G; Broyer M; Balsan S
    Kidney Int; 1976 Nov; 10(5):395-408. PubMed ID: 794558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.